[Preliminary exploration of home treatment of bortezomib in China]

Zhonghua Xue Ye Xue Za Zhi. 2020 Nov 14;41(11):951-954. doi: 10.3760/cma.j.issn.0253-2727.2020.11.014.

[Article in Chinese]

Authors

C L Zhang¹, Y Qiu¹, X X Cao¹, D Z Li¹, J Feng¹, L Zhang¹, Y Zhang¹, M H Duan¹, M Chen¹, C Yang¹, W Wang¹, Y Yao¹, D B Zhou¹, J Li¹

Affiliation

¹ Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

PMID: 33333702
PMCID: PMC7767808
DOI: 10.3760/cma.j.issn.0253-2727.2020.11.014

No abstract available

MeSH terms

Antineoplastic Agents* / therapeutic use
Boronic Acids / therapeutic use
Bortezomib* / therapeutic use
China
Home Care Services
Humans
Multiple Myeloma* / drug therapy

Substances

Antineoplastic Agents
Boronic Acids
Bortezomib